As filed with the Securities and Exchange Commission on February 27, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________________________ FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ______________________________ Pinnacle Food Group Limited (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) ______________________________ | Cayman Islands | 0762 | Not Applicable ...

Core Insights - VelocityEHS has published three significant scientific papers that enhance its leadership in AI and machine learning for workplace safety and sustainability [1] Group 1: Advancements in Ergonomics Risk Assessment - The first paper introduces an AI-powered framework using Natural Language Processing (NLP) to automate the identification of musculoskeletal disorder (MSD) risks and recommend targeted risk controls [2] - This system leverages deep learning and expert-driven machine learning models to provide actionable insights that improve workplace ergonomics and reduce injuries, moving beyond traditional risk scoring [3] - The framework aims to offer sustainable improvement strategies for MSD risk management, addressing a gap in existing research [4][5] Group 2: Revolutionizing ESG Data Management - The second paper presents an AI-driven system that automatically extracts and answers questions from extensive Environmental, Social, and Governance (ESG) reports, which often exceed 50 pages [6][7] - This innovation aims to streamline the labor-intensive process of manual extraction for audits and benchmarking, facilitating better decision-making for organizations [6][7] Group 3: Transforming Chemical Safety with AI-driven SDS Indexing - The third paper discusses an AI-powered system designed to automate the extraction of key chemical safety data from Safety Data Sheets (SDS), improving efficiency and compliance [8][9] - The automated system can index critical fields with a precision accuracy of 96 to 99%, enhancing workplace safety and regulatory compliance [11] - This innovation allows for quicker retrieval of SDS information in emergencies, potentially saving lives and setting a new standard for chemical data management [10][11] Group 4: Commitment to Innovation - VelocityEHS continues to invest in AI and machine learning to enhance workplace safety and operational performance, reflecting its commitment to pioneering advanced solutions [12] - The company is recognized as a leader in the EHS industry, with a strong focus on innovation and thought leadership [15]

Core Insights - BullFrog AI Holdings, Inc. has entered a collaboration with Eleison Pharmaceuticals to enhance clinical trial efficiency and patient insights using its BullFrog Data Networks™ AI solution [1][2] - The partnership aims to apply AI technology to analyze clinical data from Eleison's ongoing Phase 3 trial of glufosfamide, a treatment for pancreatic cancer, to improve trial design and decision-making [2][3] Company Overview - BullFrog AI is a technology-enabled drug development company that utilizes artificial intelligence and machine learning to facilitate the development of pharmaceuticals and biologics [1][4] - Eleison Pharmaceuticals focuses on developing novel chemotherapeutic treatments for rare cancers and has multiple programs in late-stage clinical development, including glufosfamide for pancreatic cancer [5] Clinical Trial Details - Glufosfamide is currently being evaluated in a pivotal Phase 3 international randomized clinical trial for second-line treatment of pancreatic cancer, which is a leading cause of cancer-related deaths in the U.S. [3] - The ongoing Phase 3 trial is expected to be completed by 2027, with glufosfamide designed to have greater specificity and reduced systemic toxicities compared to traditional treatments [3] Strategic Implications - The collaboration is expected to generate deeper insights into patient responses and safety trends, benefiting not only the glufosfamide program but also Eleison's broader oncology pipeline [4] - BullFrog AI's bfLEAP platform will evaluate safety signals and extract predictive biomarkers to support future trial designs, potentially accelerating the path to market for life-saving therapies [2][4]

Financial Performance - Total revenue for 4Q24 was $88.3 million, a 19% increase compared to $74.1 million in 4Q23[13, 23] - Software revenue for 4Q24 was $79.7 million, a 16% increase compared to $68.7 million in 4Q23[13, 23] - Drug discovery revenue for 4Q24 was $8.7 million, a 58% increase compared to $5.5 million in 4Q23[13, 23] - Total revenue for FY24 was $207.5 million, a 4.2% decrease compared to $216.7 million in FY23[13, 25] - Software revenue for FY24 was $180.4 million, a 13% increase compared to $159.1 million in FY23[13, 25] - Drug discovery revenue for FY24 was $27.1 million, a 53% decrease compared to $57.5 million in FY23[13, 25] 2025 Financial Guidance - The company expects software revenue growth of 10% - 15% in 2025[13, 43] - The company expects drug discovery revenue between $45 million and $50 million in 2025[13, 43] - The company expects operating expense growth to be less than 5% in 2025[13, 43] Key Performance Indicators - Total annual contract value (ACV) increased from $154.2 million in 2023 to $190.8 million in 2024[39] - The number of customers with ACV ≥$5M doubled from 4 in 2023 to 8 in 2024[39]

Financial Data and Key Metrics Changes - For Q4 2024, total revenues reached $50.1 million, representing a 22% year-over-year growth, exceeding the long-term growth target [20] - Full-year 2024 total revenues were $179.5 million, an 8% increase from $165.8 million in 2023, with significant growth occurring in the second half of the year [20][21] - Gross margin for Q4 was 72%, while the full-year gross margin was 74%, moving closer to the target model of 75% [24] Business Line Data and Key Metrics Changes - Analytics revenue grew 22% in Q4 compared to the same period last year and accounted for 96% of total revenue for the quarter [20][22] - The DFI eProbe systems showed strong momentum, with successful conversions from evaluations to sales for leading-edge customers [21] - Exensio modules, including process control and ML ops, are expected to drive most bookings in 2025 [15] Market Data and Key Metrics Changes - Customers in advanced logic, high bandwidth memory, and advanced packaging are investing, while other sectors exhibit a more cautious outlook [12][13] - The semiconductor industry is projected to experience mixed growth, with total revenues expected to grow at a rate approaching 15% year-over-year [17] Company Strategy and Development Direction - The company aims to expand applications for the eProbe in advanced logic and DRAM, anticipating shipment of over four machines in 2025 [14][28] - The strategy includes a shift towards a model where customers can purchase machines and optionally subscribe to application services and software [66] - The company is committed to achieving a long-term target model of 20% year-over-year revenue growth, 75% gross margin, and 20% operating margin [27] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about growth returning in the second half of 2024 and highlighted customer interest in products and solutions [12] - The outlook for 2025 reflects both short-term weaknesses in the semiconductor industry and a strong pipeline driven by macro trends such as distributed manufacturing and AI [27][28] - Management noted that while some customers are cautious, others are accelerating investments, indicating a diverse customer base [73] Other Important Information - The company reported positive operating cash flow of approximately $10 million and spent about $18 million on CapEx related to the DFI ecosystem [26] - The accounts receivable balance was elevated due to timing and billing, but management is confident in collections [60][62] Q&A Session Summary Question: Can you provide more color on the eProbe pipeline? - The eProbe sales will include both repeat sales to existing customers and new sales to new customers, with a focus on advanced logic and DRAM applications [35] Question: What is the status of the backlog? - The backlog decreased from $239 million in Q3 to $221 million, attributed to the nature of the new machine sales model [34][39] Question: How has customer receptivity to model ops been? - Customer receptivity has been high, with ongoing pilots and increased sales and marketing efforts related to model ops and guided analytics [52][53] Question: What is the impact of elevated accounts receivable on cash flow? - The elevated accounts receivable is a matter of timing and billing, with no significant concerns regarding collections [60][62] Question: How will the new sales model for DFI work? - The new model allows customers to take title of the machine while subscribing to software and application services, impacting accounts receivable [66][67] Question: Are management changes at key customers affecting business? - There is no significant impact from management changes; the business remains diverse, reducing dependency on any single customer [73][79] Question: Is there increased activity in advanced packaging? - Yes, there has been increased activity in advanced packaging, driven by the complexity of new assembly technologies [80][82] Question: Are there opportunities in HBM DRAM with Exensio? - The company is starting to penetrate HBM DRAM accounts, particularly through the eProbe, which has opened new opportunities [87][89]

Financial Data and Key Metrics Changes - In 2024, revenue increased by 12% to $6.15 billion, adjusted EBITDA grew by 14% to $2.24 billion, and AFFO increased by 11% to $1.3 billion [8][42][56] - For Q4 2024, revenue was $1.58 billion, up 11% year-on-year, adjusted EBITDA reached $605 million, up 15%, and AFFO was $368 million, up 12% [37][41][56] Business Line Data and Key Metrics Changes - Records and Information Management (RIM) business grew by 7% in 2024, with Q4 revenue of $1.26 billion, an increase of $66 million year-on-year [15][44] - Data Center revenue grew by 25% to a record $620 million in 2024, with Q4 revenue of $170 million, up 24% year-on-year [22][47] - Asset Lifecycle Management (ALM) revenue increased by 119% in 2024, with Q4 revenue of $112 million, up 118% year-on-year [27][51] Market Data and Key Metrics Changes - The growth portfolio, including digital solutions and data center management, represented 25% of total revenue in 2024, up from 15% at the beginning of the Matterhorn initiative [12] - The company secured significant contracts across various sectors, including a four-year contract with a Fortune 500 company for records management and additional services [16] Company Strategy and Development Direction - The company aims to continue double-digit growth driven by recurring revenue streams and strong macro factors supporting demand for growth businesses [14] - A focus on cross-selling to a loyal customer base, which includes 95% of the Fortune 1000, is a key strategy for growth [14] - The company has authorized a 10% increase in its quarterly dividend, reflecting confidence in future performance [14][55] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving consolidated growth in excess of 10% for the foreseeable future, supported by strong demand and operational efficiencies [13][14] - The company anticipates another record year in 2025, with revenue projected between $6.65 billion and $6.8 billion, representing year-on-year growth of 9% at the midpoint [56][57] Other Important Information - The company has a strong balance sheet with net lease adjusted leverage at 5.0 times, the lowest level since its REIT conversion in 2014 [54] - The company is focused on improving profitability in its Consumer Storage business, which has been deemphasized in favor of more profitable segments [102][105] Q&A Session Summary Question: Can you elaborate on how organic growth in the ALM business in 4Q was split between volumes and component prices? - Management indicated that organic growth was largely volume-driven, with component prices remaining generally flat [63][66] Question: What's your expectation for RIM volumes in Q1 and the balance of 2025? - Management expects RIM volumes to be flat to slightly up, with mid-single-digit overall revenue growth anticipated [71][72] Question: Can you discuss the implications of the DeepSeek announcement on the Data Center business? - Management noted strong pipeline activity and did not foresee any reduction in CapEx expenditure from large customers despite market noise [78][82] Question: What drove the churn in Q4 and what are your expectations for 2025? - Management explained that churn was due to a couple of long-term clients moving to cloud solutions, but overall churn is expected to be below historical levels in 2025 [94][95] Question: Can you provide insights on cash renewal spreads and capital recycling in your data center portfolio? - Management expects cash renewal spreads to continue rising due to demand outpacing supply, and noted no specific plans for capital recycling at this time [120][121]

As filed with the U.S. Securities and Exchange Commission on February 12, 2025. Registration No. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DIGINEX LIMITED (Exact Name of Registrant as Specified in Its Charter) Cayman Islands 7389 N/A (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) Smart-Space Fintech 2, Roo ...

As filed with the Securities and Exchange Commission on January 31, 2025 Registration No. 333-283773 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Odysight.ai Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Nevada 7370 47-4257143 (I.R.S. Employer Identification No.) Sui ...

As filed with the U.S. Securities and Exchange Commission on January 14, 2025 Registration No. 333-283112 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No.1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 KNOREX LTD. (Exact name of registrant as specified in its charter) Cayman Islands 7370 Not Applicable (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial (I.R.S. Employer Identification Number) 21 Merchant Road, ...

As filed with the U.S. Securities and Exchange Commission on January 7, 2025. Registration No. 333-281144 UNDER THE SECURITIES ACT OF 1933 ______________________ Plum Acquisition Corp. IV (Exact Name of Registrant as Specified in its Charter) ______________________ | Cayman Islands | 6770 | 98-1795710 | | --- | --- | --- | | (State or Other Jurisdiction of | (Primary Standard Industrial | (IRS Employer | | Incorporation or Organization) | Classification Code Number) | | (IRS Employer UNITED STATES SECURITIE ...